Company Filing History:
Years Active: 2025
Title: Neul Ha: Innovator in GLP-1 Receptor Agonist Development
Introduction
Neul Ha is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GLP-1 receptors. His innovative work has the potential to impact the treatment of various diseases associated with GLP-1 activity.
Latest Patents
Neul Ha holds a patent for a GLP-1 receptor agonist. The invention relates to a compound represented by Formula 1, wherein A, B, L, X, and R are as described in the patent documentation. This compound, or a pharmaceutically acceptable salt thereof, serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of diseases associated with GLP-1 activity. He has 1 patent to his name.
Career Highlights
Neul Ha is currently associated with Hyundai Pharm Co., Ltd., where he continues to advance his research and development efforts. His work at Hyundai Pharm has positioned him as a key player in the pharmaceutical industry, focusing on innovative solutions for health challenges.
Collaborations
Some of his notable coworkers include Han Kyu Lee and Jeong-Un Hwang. Their collaborative efforts contribute to the dynamic research environment at Hyundai Pharm.
Conclusion
Neul Ha's contributions to the field of GLP-1 receptor agonists exemplify the importance of innovation in pharmaceuticals. His work not only enhances our understanding of GLP-1 activity but also paves the way for new therapeutic options.